Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

878.45 -4.88 (-0.55%)
Official Closing Price Updated: 7:00 PM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,023,673
Open 882.33
Bid (Size) 878.70 (1)
Ask (Size) 888.00 (1)
Prev. Close 883.33
Today's Range 876.00 - 884.61
52wk Range 434.34 - 885.06
Shares Outstanding N/A
Dividend Yield 0.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade. 
Via The Motley Fool
Will Walmart Reach a Trillion-Dollar Market Cap by 2030?
This seemingly unlikely non-tech name quietly deserves to be on the list of contenders that could achieve the feat in the foreseeable future. 
Via The Motley Fool

Performance

YTD
+48.34%
+48.34%
1 Month
+13.92%
+13.92%
3 Month
+15.18%
+15.18%
6 Month
+51.52%
+51.52%
1 Year
+96.21%
+96.21%

More News

Read More
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
Via The Motley Fool
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Via The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
Via Benzinga
Eli Lilly and Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
Via Benzinga
Exit Alert: 3 Stocks to Offload Before the Downturn
Via InvestorPlace
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Via Investor's Business Daily
Stock Market Hits Highs; Tame Inflation, Fed Meeting, Apple, Broadcom, Oracle, Tesla: Weekly Review
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
7 A-Rated Biotech Stocks Worth Betting on in June
Via InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
Via InvestorPlace
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
Via The Motley Fool
Weight Loss Drugs: Are They Really Magic?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
JPMorgan's $500M Venture Capital Fund Bets Big On Weight-Loss Drugs: 'They're All The Rage'
Via Benzinga
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks to Buy as Ozempic Surges in Popularity
Via InvestorPlace
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.
Via The Motley Fool
Down 57%, Is AbCellera Biologics a Buy on the Dip?
Via The Motley Fool
4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024
Via InvestorPlace
Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?
Via Benzinga
3 Stocks Quietly Preparing for a 10X Surge: June Edition
Via InvestorPlace
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Trending Stocks With Momentum on Their Side
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.